In today’s briefing:
- Bumitama Agri: Lagging CPO Price Action; Large Special Dividend Possible at FY21 Results Briefing
- Raffles Medical (RFMD SP) – Pivot in SG Travel Rules, Testing Regime and Its Implications
Bumitama Agri: Lagging CPO Price Action; Large Special Dividend Possible at FY21 Results Briefing
- Bumitama Agri (BAL SP) is a pure-play CPO play on SGX which like the rest of its peers has lagged the price of CPO by a mile.
- What could be the catalyst to change this? We preview FY21 results which will be announced on 28th February and its dividend outlook going into FY22.
- BAL should take a page from the Geo Energy Resources (GERL SP) playbook and start to pay out aggressive bi-annual dividends to get Mr. Market’s attention.
Raffles Medical (RFMD SP) – Pivot in SG Travel Rules, Testing Regime and Its Implications
- Singapore will apply streamlined COVID-19 rules from 25 February 2022, with a focus on vaccination status instead of an aggressive testing and surveillance regime
- We previously discussed how Raffles Medical benefits as the primary testing services provider at Changi airport and by facilitating Singapore’s vaccination drive
- Given the latest pivot in border protocols, and taking into account Singapore’s high vaccination rates, we discuss whether our initial investment hypothesis remains intact
Before it’s here, it’s on Smartkarma
